Clinical Trial Update: Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing left atrial appendage closure to standard antiplatelet therapy in patients with atrial fibrillation undergoing PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Myocardial Infarction

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Myocardial Infarction | Phase 2 | Status: UNKNOWN